Browse
Explore conditions, clinical trials, and the organisations running them.
Find a trial
Search by condition, then narrow by status and aim.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
129572 trials found · Page 6479 of 6479
-
Mystery device trial: no details released
Knowledge-focused Details not publishedSponsor: [Redacted] • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Mystery device trial keeps details secret
Knowledge-focused Details not publishedSponsor: [Redacted] • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Mystery device trial: no details released
Knowledge-focused Details not publishedSponsor: [Redacted] • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Mystery device trial: details hidden
Knowledge-focused Details not publishedSponsor: [Redacted] • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:27 UTC
-
Secret device trial raises more questions than answers
Knowledge-focused Details not publishedSponsor: [Redacted] • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Mystery device trial: no details released
Knowledge-focused Details not publishedSponsor: [Redacted] • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Mystery device trial: details kept secret
Knowledge-focused Details not publishedSponsor: [Redacted] • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Mystery device trial keeps details secret
Knowledge-focused Details not publishedSponsor: [Redacted] • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New targeted cancer therapy begins first human testing
Disease control Not yet recruitingThe purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, Pharmacokinetics (PK), and preliminary clinical activity of M7437 in participants with locally advanced or metastatic solid tumors with known Ly6E expression, including non-small cell lung can…
Phase 1 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jan 26, 2026 13:59 UTC
-
Gut health secrets in Low-Carb diet revealed!
CancelledThe aim of the study is to investigate dynamic changes in gut microbiome and its metabolites among overweight and obese participants while they are on a modified Atkins Diets.
Sponsor: Westlake University
Last updated Nov 25, 2025 13:45 UTC
-
Massive 5-Million person study reveals new insights about blood fats
OngoingCloser examination of granular lipid data in a large population offers numerous opportunities to generate new knowledge, ranging from studies examining concordance between commonly used lipid parameters to phenotypic characterization of rare or extreme disorders of lipid metaboli…
Sponsor: Johns Hopkins University
Last updated Nov 24, 2025 13:56 UTC
-
New hope for advanced breast cancer patients with specific gene mutation
Disease control Expanded accessThe purpose of this Cohort Treatment Plan is to allow access to alpelisib for patients diagnosed with HR-positive, HER2-negative advanced breast cancer with mutated phosphoinositide 3-kinase who progressed on or after AI treatment. The patient's Treating Physician should follow t…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jan 13, 2026 15:13 UTC